Sowell Financial Services LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$62.15 - $90.32 $24,114 - $35,044	-388 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$43.82 - $85.37 $3,856 - $7,512	88 Added 29.33%	388 $30,000
Q3 2020 Nov 12, 2020	BUY	$33.21 - $51.27 $4,981 - $7,690	150 Added 100.0%	300 $13,000
Q2 2020 Aug 13, 2020	SELL	$26.12 - $43.27 $29,672 - $49,154	-1,136 Reduced 88.34%	150 $6,000
Q1 2020 May 12, 2020	BUY	$20.56 - $63.12 $3,412 - $10,477	166 Added 14.82%	1,286 $37,000
Q4 2019 Feb 07, 2020	BUY	$28.14 - $73.01 $29,715 - $77,098	1,056 Added 1650.0%	1,120 $71,000
Q3 2019 Nov 14, 2019	BUY	$26.26 - $34.86 $1,680 - $2,231	64 New	64 $2,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.77B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.